Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz, Dieke J. Van Rees, Hanke L. Matlung, Godelieve A.M. Tytgat, Katka Franke

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numbere003983
JournalJournal for ImmunoTherapy of Cancer
Issue number12
Publication statusPublished - 1 Dec 2021


  • cytokines
  • immunotherapy
  • neuroblastoma

Cite this